Igene Biotechnology, Inc. (IGNE)

USD 0.0

(0.0%)

Total Debt Summary of Igene Biotechnology, Inc.

Igene Biotechnology, Inc.'s latest annual total debt in 2009 was 6.79 Million USD , up 26.95% from previous year.
Igene Biotechnology, Inc.'s latest quarterly total debt in 2010 Q3 was 7.33 Million USD , up 0.1% from previous quarter.
Igene Biotechnology, Inc. reported annual total debt of 5.35 Million USD in 2008, down -72.3% from previous year.
Igene Biotechnology, Inc. reported annual total debt of 19.33 Million USD in 2007, up 20.68% from previous year.
Igene Biotechnology, Inc. reported quarterly total debt of 7.32 Million USD for 2010 Q2, up 1.83% from previous quarter.
Igene Biotechnology, Inc. reported quarterly total debt of 7.33 Million USD for 2010 Q3, up 0.1% from previous quarter.

Annual Total Debt Chart of Igene Biotechnology, Inc. (2009 - 1999)

Historical Annual Total Debt of Igene Biotechnology, Inc. (2009 - 1999)

Year	Total Debt	Total Debt Growth
2009	6.79 Million USD	26.95%
2008	5.35 Million USD	-72.3%
2007	19.33 Million USD	20.68%
2006	16.01 Million USD	0.0%
2003	10.65 Million USD	-4.1%
2002	11.11 Million USD	0.35%
2001	11.07 Million USD	35.42%
2000	8.17 Million USD	7.84%
1999	7.58 Million USD	0.0%

Year	Total Debt	Total Debt Growth
2010 Q1	7.19 Million USD	5.89%
2010 Q2	7.32 Million USD	1.83%
2010 Q3	7.33 Million USD	0.1%
2009 Q4	6.79 Million USD	-7.72%
2009 Q3	7.36 Million USD	18.16%
2009 FY	6.79 Million USD	26.95%
2009 Q1	5.9 Million USD	10.25%
2009 Q2	6.23 Million USD	5.61%
2008 Q2	20.42 Million USD	2.76%
2008 FY	5.35 Million USD	-72.3%
2008 Q4	5.35 Million USD	-74.48%
2008 Q3	20.97 Million USD	2.7%
2008 Q1	19.87 Million USD	2.84%
2007 Q3	13.77 Million USD	4.17%
2007 FY	19.33 Million USD	20.68%
2007 Q4	19.33 Million USD	40.29%
2007 Q2	13.22 Million USD	-18.55%
2007 Q1	16.24 Million USD	1.39%
2006 FY	16.01 Million USD	0.0%
2006 Q3	15.82 Million USD	0.0%
2006 Q4	16.01 Million USD	1.2%
2004 Q3	10.46 Million USD	0.0%
2004 Q1	10.65 Million USD	0.0%
2004 Q2	10.46 Million USD	-1.79%
2003 Q3	10.85 Million USD	-1.36%
2003 FY	10.65 Million USD	-4.1%
2003 Q4	10.65 Million USD	-1.85%
2003 Q2	11 Million USD	-1.78%
2003 Q1	11.2 Million USD	0.86%
2002 Q4	11.11 Million USD	-10.18%
2002 Q3	12.37 Million USD	-0.03%
2002 Q1	11.82 Million USD	6.76%
2002 FY	11.11 Million USD	0.35%
2002 Q2	12.37 Million USD	4.68%
2001 FY	11.07 Million USD	35.42%
2001 Q3	9.67 Million USD	4.8%
2001 Q2	9.22 Million USD	2.72%
2001 Q4	11.07 Million USD	14.49%
2001 Q1	8.98 Million USD	9.88%
2000 Q3	7.57 Million USD	0.0%
2000 Q1	7.57 Million USD	0.0%
2000 FY	8.17 Million USD	7.84%
2000 Q4	8.17 Million USD	7.92%
2000 Q2	7.57 Million USD	0.0%
1999 FY	7.58 Million USD	0.0%

Peer Total Debt Comparison of Igene Biotechnology, Inc.

Name	Total Debt	Total Debt Difference
Allied Energy Corporation	4.34 Million USD	-56.34%
Earth Alive Clean Technologies Inc.	456.01 Thousand USD	-1390.41%
Lotus Bio-Technology Development Corp.	- USD	-Infinity%
MagIndustries Corp.	- USD	-Infinity%
Itafos Inc.	103.3 Million USD	93.421%
Potash America, Inc.	285.01 Thousand USD	-2284.622%
Yara International ASA	4.23 Billion USD	99.839%
Yara International ASA	4.21 Billion USD	99.839%